"D&H National Research Centers is a dedicated Phase I­-III full-service Clinical Research Facility, with more than 40 years of combined experience. Having our multi-­specialty Physician Investigators (PI) enables us to engage in many Pharmaceutical trials. Our Mission is to provide quality care to our patients in an atmosphere of excellence, compassion, integrity, and innovation."

During the past decade, D&H National Research Centers, Inc. conducted 5 clinical trials. In the 10-year time frame, 5 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 5 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

Out of the total clinical trials conducted in "D&H National Research Centers, Inc." #1 sponsor was "AOBiome LLC" with 1 trials, followed by "Idorsia Pharmaceuticals Ltd." with 1 trials sponsored, "InDex Pharmaceuticals" with 1 trials sponsored, "Navidea Biopharmaceuticals" with 1 trials sponsored and "Sky Medical Supplies & Equipments, LLC" with 1 trials sponsored. Other sponsors include -5 different institutions and companies that sponsored additional 5 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "D&H National Research Centers, Inc." #1 collaborator was "bioRASI, LLC" with 1 trials as a collaborator. Other collaborators include -1 different institutions and companies that were collaborators in the rest 1 trials.

According to Clinical.Site data, the most researched conditions in "D&H National Research Centers, Inc." are "Atopic Dermatitis" (1 trials), "Coronavirus" (1 trials), "Covid-19" (1 trials), "Insomnia" (1 trials) and "Rheumatoid Arthritis" (1 trials). Many other conditions were trialed in "D&H National Research Centers, Inc." in a lesser frequency.

Most popular intervention types in "D&H National Research Centers, Inc." are "Drug" (3 trials), "Biological" (1 trials) and "Diagnostic Test" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (2 trials), "B244" (1 trials), "Cobitolimod 250 mg" (1 trials), "Cobitolimod 500 mg" (1 trials) and "Daridorexant 10 mg" (1 trials). Other intervention names were less common.

The vast majority of trials in "D&H National Research Centers, Inc." are 5 trials for "All" genders.

Currently, there are NaN active trials in "D&H National Research Centers, Inc.". undefined are not yet recruiting, 3 are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 1 completed trials in D&H National Research Centers, Inc., undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in D&H National Research Centers, Inc., 0 "Phase 1" clinical trials were conducted, 2 "Phase 2" clinical trials and 2 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 1 trials that are defined as “Not Applicable".